Covered recipient · General Payments record
GLORIA A VANKLOMPENBERG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$835.62
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $484.27 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $171.53 | 2 |
| Novo Nordisk AS | $135.89 | 3 |
| Acerta Pharma LLC | $108.50 | 3 |
| PFIZER INC. | $40.82 | 2 |
| Amgen Inc. | $27.53 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $153.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125110739 | CMS |
| Abbott Laboratories | $17.64 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125110741 | CMS |
| Amgen Inc. | $13.61 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111731613 | CMS |
| Amgen Inc. | $13.92 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117405136 | CMS |
| AstraZeneca Pharmaceuticals LP | $77.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105821389 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.10 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105859906 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.15 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104506848 | CMS |
| Novo Nordisk Inc | $103.91 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096913550 | CMS |
| Novo Nordisk Inc | $18.00 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096928226 | CMS |
| Novo Nordisk Inc | $13.98 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569466 | CMS |
| PFIZER INC. | $23.32 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132114983 | CMS |
| PFIZER INC. | $17.50 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131402055 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.